Statens Serum Institut
OrganisationROR
Trials
Collaborator, Phase 4, Status unknown, 160 people, 10 Aug 2012
Collaborator, Phase 2/3, Completed, 641 people, 11 Nov 2005
Collaborator, Phase 2/3, Completed, 2,628 people, 8 Sept 2005
Grants and prizes
HORIZON-TMA-MSCA-DN, Effective Delivery of Nucleic Acid Therapeutics via Designed Nanocarriers, 101168881, €301.8k, 2024–2028, 10 Jul 2024
Sources: cordis.europa.eu